Amino acid transporter, SLC6A14, might represent a possible therapeutic target for pancreatic cancer, and it was found to be upregulated in patient-derived xenografts and primary pancreatic tumors, as well as colorectal cancer (Gupta et al., 2005; Coothankandaswamy et al., 2016). This evidence concerns the gene SLC6A14 and pancreatic neoplasm.